UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 


FORM 10-Q
 
(Mark One)
 x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended March 31, 2007
OR
 o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from _________to_________
 
Commission File Number
 
000-23115
CTI INDUSTRIES CORPORATION
(Exact name of Registrant as specified in its charter)

Illinois
36-2848943
(State or other jurisdiction of
(I.R.S. Employer Identification Number)
incorporation or organization)
 
 
 
22160 N. Pepper Road
 
Barrington, Illinois
60010
(Address of principal executive offices)
(Zip Code)

(847)382-1000
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  Yes þ     No o
 
Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of “accelerated filer and large accelerated filer” in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o     Accelerated filer  o    Non-accelerated filer þ 
 
Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).  Yes o No þ

The number of shares outstanding of the Registrant’s common stock as of May 21, 2007 was 2,293,027.
 


INDEX

PART I - FINANCIAL INFORMATION
   
         
Item No. 1
 
Financial Statements
 
3
Item No. 2
 
Management’s Discussion and Analysis of Financial Condition and Results of Operations
  15
Item No. 3
 
Quantitative and Qualitative Disclosures Regarding Market Risk
 
20
Item No. 4
 
Controls and Procedures
 
21
         
PART II - OTHER INFORMATION
   
         
Item No. 1
 
Legal Proceedings.
 
22
Item No. 1A
 
Risk Factors
 
22
Item No. 2
 
Unregistered Sales of Equity Securities and Use of Proceeds
 
22
Item No. 3
 
Defaults Upon Senior Securities
 
22
Item No. 4
 
Submission of Matters to a Vote of Security Holders
 
22
 
Other Information
 
22
Item No. 6
 
Exhibits
 
23

2

 

PART I. FINANCIAL INFORMATION

This quarterly report includes both historical and “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. We have based these forward-looking statements on our current expectations and projections about future results. Words such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “predict,” “potential,” “continue,” or similar words are intended to identify forward-looking statements, although not all forward-looking statements contain these words. Although we believe that our opinions and expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements, and our actual results may differ substantially from the views and expectations set forth in this quarterly report on Form 10-Q. We disclaim any intent or obligation to update any forward-looking statements after the date of this quarterly report to conform such statements to actual results or to changes in our opinions or expectations. These forward-looking statements are affected by risks, uncertainties and assumptions that we make, including, among other things, the factors that are described in “Item No. 1A - Risk Factors” in our 2006 Annual Report on Form 10-K filed with the Securities and Exchange Commission on April 10, 2007 as the same may be updated or amended in our quarterly reports on Form 10-Q.

Item 1. Financial Statements

The following condensed consolidated financial statements of the Registrant are attached to this Form 10-Q:

1.  Interim Balance Sheet as at March 31, 2007 (unaudited) and Balance Sheet as at December 31, 2006;

2.  Interim Statements of Operations (unaudited) for the three months ended March 31, 2007 and March 31, 2006;

3.  Interim Statements of Cash Flows (unaudited) for the three months ended March 31, 2007 and March 31, 2006;

4.  Notes to Condensed Consolidated Financial Statements.

The Financial Statements reflect all adjustments, which are, in the opinion of management, necessary for a fair statement of results for the periods presented.
 
3


CTI Industries Corporation and Subsidiaries
Consolidated Statements of Cash Flows (Unaudited)
 
   
For the Quarter Ended March 31,
 
 
 
2007
 
2006
 
 
 
 
 
Restated
 
Cash flows from operating activities:
         
Net (loss) income
 
$
(52,212
)
$
219,768
 
Adjustment to reconcile net (loss) income to cash
             
provided by (used in) operating activities:
             
Depreciation and amortization
   
359,399
   
351,428
 
Amortization of debt discount
   
23,888
   
20,414
 
Minority interest in loss of subsidiary
   
(34
)
 
(80
)
Provision for losses on accounts receivable
   
27,224
   
45,000
 
Provision for losses on inventories
   
16,759
   
22,500
 
Deferred income taxes
   
(46,407
)
 
38,188
 
Change in assets and liabilities:
             
Accounts receivable
   
372,405
   
(1,300,126
)
Inventories
   
(289,933
)
 
(350,181
)
Prepaid expenses and other assets
   
84,229
   
128,518
 
Trade payables
   
132,774
   
(331,430
)
Accrued liabilities
   
(99,297
)
 
210,947
 
             
 Net cash provided by (used in) operating activities
   
528,795
   
(945,054
)
               
Cash flows from investing activity:
             
Purchases of property, plant and equipment
   
(326,643
)
 
(61,219
)
               
 Net cash used in investing activity
   
(326,643
)
 
(61,219
)
               
Cash flows from financing activities:
             
Checks written in excess of bank balance
   
93,620
   
(338,237
)
Net change in revolving line of credit
   
(96,457
)
 
(215,492
)
Proceeds from issuance of long-term debt and warrants
             
(received from related party $1,000,000 in 2006)
   
0
   
2,423,634
 
Repayment of long-term debt (related parties $15,000 in 2006)
   
(268,343
)
 
(310,783
)
Proceeds from exercise of stock options
   
46,271
   
0
 
Proceeds from issuance of stock
   
104,933
   
0
 
Cash paid for deferred financing fees
   
(2,500
)
 
(180,506
)
             
Net cash (used in) provided by financing activities
   
(122,476
)
 
1,378,616
 
               
Effect of exchange rate changes on cash
   
2,150
   
5,887
 
               
Net increase in cash
   
81,826
   
378,230
 
               
Cash at beginning of period
   
384,565
   
261,982
 
               
Cash and cash equivalents at end of period
 
$
466,391
 
$
640,212
 
               
Supplemental disclosure of cash flow information:
             
Cash payments for interest
 
$
319,713
 
$
303,979
 
               
Cash payments for taxes
 
$
10,000
 
$
-
 
               
Supplemental disclosure of non-cash investing and financing activities:               
Stock subscription receivable
 
$
110,251
 
$
-
 
 
See accompanying notes to condensed consolidated unaudited statements
 
4


CTI Industries Corporation and Subsidiaries
Consolidated Statements of Operations (Unaudited)
 
   
For the Quarter Ended March 31,
 
   
2007
 
2006
 
Net Sales
 
$
8,278,874
 
$
8,156,223
 
               
Cost of Sales
   
6,376,187
   
6,202,908
 
               
Gross profit
   
1,902,687
   
1,953,315
 
               
Operating expenses:
             
General and administrative
   
1,212,169
   
1,017,474
 
Selling
   
205,969
   
176,626
 
Advertising and marketing
   
290,790
   
218,261
 
           
Total operating expenses
   
1,708,928
   
1,412,361
 
               
Income from operations
   
193,759
   
540,954
 
               
Other income (expense):
             
Interest expense
   
(336,584
)
 
(336,445
)
Interest income
   
2,000
   
5,822
 
Foreign currency gain
   
52,172
   
47,545
 
             
Total other expense
   
(282,412
)
 
(283,078
)
               
(Loss) income before income taxes and minority interest
   
(88,653
)
 
257,876
 
               
Income tax (benefit) expense
   
(36,407
)
 
38,188
 
               
(Loss) income before minority interest
   
(52,246
)
 
219,688
 
               
Minority interest in loss of subsidiary
   
(34
)
 
(80
)
               
Net (loss) income
 
$
(52,212
)
$
219,768
 
               
Basic income per common share
 
$
(0.02
)
$
0.11
 
               
Diluted income per common share
 
$
(0.02
)
$
0.10
 
               
Weighted average number of shares and equivalent shares
             
of common stock outstanding:
             
Basic
   
2,156,783
   
2,036,474
 
               
Diluted
   
2,156,783
   
2,166,892
 
 
See accompanying notes to condensed consolidated unaudited statements
 
5


CTI Industries Corporation and Subsidiaries
Consolidated Balance Sheets
 
   
March 31, 2007
 
December 31, 2006
 
   
(Unaudited)
     
ASSETS
         
Current assets:
         
Cash and cash equivalents
 
$
466,391
 
$
384,565
 
Accounts receivable, (less allowance for doubtful accounts of $238,000
         
and $210,000, respectively)
   
5,998,119
   
6,442,765
 
Inventories, net
   
8,233,462
   
7,974,113
 
Net deferred income tax asset
   
985,730
   
1,025,782
 
Prepaid expenses and other current assets
   
856,313
   
664,020
 
               
 Total current assets
   
16,540,015
   
16,491,245
 
               
Property, plant and equipment:
             
Machinery and equipment
   
18,772,064
   
18,763,007
 
Building
   
2,689,956
   
2,689,956
 
Office furniture and equipment
   
2,088,183
   
2,087,708
 
Land
   
250,000
   
250,000
 
Leasehold improvements
   
453,802
   
459,502
 
Fixtures and equipment at customer locations
   
2,330,483
   
2,330,483
 
Projects under construction
   
562,470
   
289,229
 
     
27,146,958
   
26,869,885
 
Less : accumulated depreciation and amortization
   
(18,597,521
)
 
(18,277,611
)
               
 Total property, plant and equipment, net
   
8,549,437
   
8,592,274
 
               
Other assets:
             
Deferred financing costs, net
   
184,516
   
207,049
 
Goodwill
   
989,108
   
989,108
 
Net deferred income tax asset
   
187,561
   
101,102
 
Other assets (due from related party $48,000 and $30,000, respectively)
   
228,265
   
264,161
 
               
 Total other assets
   
1,589,450
   
1,561,420
 
               
TOTAL ASSETS
 
$
26,678,902
 
$
26,644,939
 
LIABILITIES AND STOCKHOLDERS' EQUITY
             
Current liabilities:
             
Checks written in excess of bank balance
 
$
202,150
 
$
108,704
 
Trade payables
   
3,526,951
   
3,410,869
 
Line of credit
   
6,221,404
   
6,317,860
 
Notes payable - current portion
   
919,806
   
948,724
 
Notes payable - officers, current portion, net of debt discount
   
2,157,065
   
2,155,284
 
Accrued liabilities
   
1,689,518
   
1,701,933
 
               
Total current liabilities
   
14,716,894
   
14,643,374
 
               
Long-term liabilities:
             
Other liabilities (related parties $1,218,000 and $1,274,000)
   
1,228,460
   
1,294,272
 
Notes payable
   
4,668,845
   
4,866,008
 
Notes payable - officers, subordinated, net of debt discount
   
748,795
   
726,688
 
Total long-term liabilities
   
6,646,100
   
6,886,968
 
Minority interest
   
12,638
   
12,672
 
Stockholders' equity:
             
Preferred Stock -- no par value 2,000,000 shares authorized
             
0 shares issued and outstanding
   
-
   
-
 
Common stock - no par value, 5,000,000 shares authorized,
             
2,491,411 and 2,412,297 shares issued, 2,221,211 and
             
2,142,097 shares outstanding, respectively
   
3,764,020
   
3,764,020
 
Paid-in-capital
   
6,362,043
   
6,100,587
 
Warrants issued in connection with subordinated debt and bank debt
   
1,038,487
   
1,038,487
 
Accumulated deficit
   
(4,498,109
)
 
(4,445,897
)
Accumulated other comprehensive earnings
   
(305,389
)
 
(297,490
)
Less:
             
 Treasury stock - 270,200 shares
   
(1,057,782
)
 
(1,057,782
)
               
 Total stockholders' equity
   
5,303,270
   
5,101,925
 
               
TOTAL LIABILITIES & STOCKHOLDERS' EQUITY
 
$
26,678,902
 
$
26,644,939
 
 
See accompanying notes to condensed consolidated unaudited statements
 
6


CTI Industries Corporation and Subsidiaries
Consolidated Earnings per Share
  
   
Quarter Ended March 31,
 
   
2007
 
2006
 
Basic
         
Average shares outstanding:
             
Weighted average number of shares of
             
common stock outstanding during the
             
period
   
2,156,783
   
2,036,473
 
               
Net (loss) income:
             
Net (loss) income
 
$
(52,212
)
$
219,768
 
               
Amount for per share computation
 
$
(52,212
)
$
219,768
 
               
Per share amount
 
$
(0.02
)
$
0.11
 
               
Diluted
             
Average shares outstanding:
             
Weighted average number of shares of
             
 common stock outstanding during the
             
 period
   
2,156,783
   
2,036,473
 
Net additional shares assuming stock
             
 options and warrants exercised and
             
 proceeds used to purchase treasury
             
 stock
   
-
   
130,419
 
Weighted average number of shares and
             
 equivalent shares of common stock
             
 outstanding during the period
   
2,156,783
   
2,166,892
 
               
Net (loss) income:
             
Net (loss) income
 
$
(52,212
)
$
219,768
 
               
Amount for per share computation
 
$
(52,212
)
$
219,768
 
               
Per share amount
 
$
(0.02
)
$
0.10
 
 
See accompanying notes to condensed consolidated unaudited statements
 
7

 
CTI Industries Corporation and Subsidiaries
Notes to Unaudited Condensed Consolidated Financial Statements

Note 1 - Basis of Presentation

The accompanying consolidated financial statements are unaudited but in the opinion of management contain all the adjustments (consisting of those of a normal recurring nature) considered necessary to present fairly the consolidated financial position and the consolidated results of operations and consolidated cash flows for the periods presented in conformity with generally accepted accounting principles for interim consolidated financial information and the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all the information and footnotes required by accounting principles generally accepted in the United States of America for complete financial statements. Operating results for the three months ended March 31, 2007 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2007. For further information, refer to the consolidated financial statements and footnotes thereto included in the Company's annual report on Form 10-K for the fiscal year ended December 31, 2006.

Principles of consolidation and nature of operations:

The consolidated financial statements include the accounts of (“CTI-US”) and its wholly-owned subsidiaries, CTI Balloons Limited, CTI Helium, Inc. and CTF International S.A. de C.V., as well as its majority-owned subsidiaries CTI Mexico S.A. de C.V., and Flexo Universal, S.A. de C.V. (the “Company”). All significant intercompany transactions and accounts have been eliminated in consolidation. The Company (i) designs, manufactures and distributes balloon products throughout the world and (ii) operates systems for the production, lamination, coating and printing of films used for food packaging and other commercial uses and for conversion of films to flexible packaging containers and other products.

Use of estimates:

In preparing financial statements in conformity with accounting principles generally accepted in the United States of America, management makes estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amount of revenue and expenses during the reporting period in the financial statements and accompanying notes. Actual results may differ from those estimates. The Company’s significant estimates include reserves for doubtful accounts, reserves for the lower of cost or market of inventory and recovery value of goodwill.

Earnings per share.

Basic earnings per share is computed by dividing the income available to common shareholders, net earnings, less redeemable preferred stock dividends and redeemable common stock accretion, by the weighted average number of shares of common stock outstanding during each period.

Diluted earnings per share is computed by dividing the net earnings by the weighted average number of shares of common stock and common stock equilvalents (redeemable common stock, stock options and warrants), unless anti-dilutive, during each period.
 
8


Shares to be issued upon the exercise of options and warrants aggregating 315,767 and 466,030, respectively, as of March 31, 2007 and 2006 are not included in the computation of loss per share as their effect is antidilutive.
 
Note 2 - Legal Proceedings

On December 20, 2006, Pliant Corporation filed an action against the Company in the Circuit Court of Cook County, Illinois. In the action, Pliant claims that there is due from the Company to Pliant the sum of $245,000 for goods sold and delivered by Pliant to the Company as well as interest on such amount. On February 21, 2007, the Company filed an answer to the complaint and counterclaim denying liability and asserting certain claims against Pliant for damages for the sale by Pliant to the Company of defective products. Management intends to defend the claims of Pliant in this action and to pursue its counterclaims and believes that the Company has established adequate reserves regarding the claim.

The Company is party to certain lawsuits arising in the normal course of business. The ultimate outcome of these matters is unknown but, in the opinion of management, the settlement of these matters is not expected to have a significant effect on the future financial position or results of operations of the Company.

Note 3 - Comprehensive (Loss) Income

Other comprehensive (loss) is comprised of (loss) from foreign currency translation amounting to $7,899 and $30,138 for the three months ended March 31, 2007 and 2006, respectively. As a result, accumulated comprehensive (loss) income amounts to $(60,111) and $189,550 for the periods ended March 31, 2007 and 2006, respectively.

Note 4 - Stock-Based Compensation

On January 1, 2006, the Company adopted Statement of Financial Accounting Standards No. 123(R), “Share-Based Payment” (“SFAS 123(R)”). Prior to the adoption of SFAS 123(R), the Company had adopted the disclosure-only provisions of SFAS 123 and accounted for employee stock-based compensation under the intrinsic value method, and no expense related to stock options was recognized. Under this method, the Company’s consolidated financial statements as of and for the three months ended March 31, 2006 reflect the impact of SFAS 123(R), while the consolidated financial statements for prior periods have not been restated to reflect, and do not include, the impact of SFAS 123(R). SFAS 123(R) amends SFAS No. 95, “Statement of Cash Flows,” to require that excess tax benefits be reported as a financing cash flow rather than as an operating cash flow. Adoption of SFAS 123(R) did not have a material impact on the consolidated statements of cash flows for the three months ended March 31, 2006.

As of March 31, 2007, the Company had four stock-based compensation plans pursuant to which stock options may be granted. The Plans provide for the award of options, which may either be incentive stock options (“ISOs”) within the meaning of Section 422A of the Internal Revenue Code of 1986, as amended (the “Code”) or non-qualified options (“NQOs”) which are not subject to special tax treatment under the Code. 
 
9


Under the Company’s 1997 Stock Option Plan (effective July 1, 1997), a total of 119,050 shares of Common Stock were reserved for issuance under the Stock Option Plan. As of March 31, 2007, 87,305 shares of Common Stock have been granted and remain outstanding. During the three months ended March 31, 2007 4,762 options were exercised and proceeds of $30,001 were received from this Plan.

On March 19, 1999, the Board of Directors approved for adoption, effective May 6, 1999, the 1999 Stock Option Plan (“Plan”). The Plan authorizes the grant of options to purchase up to an aggregate of 158,733 shares of the Company’s Common Stock. As of March 31, 2007, 36,906 options had been granted under the 1999 Stock Option Plan and remain outstanding. During the three months ended March 31, 2007, 16,668 options were exercised and proceeds of $31,503 were received from this plan.
 
On April 12, 2001, the Board of Directors approved for adoption, effective December 27, 2001, the 2001 Stock Option Plan (“Plan”). The Plan authorizes the grant of options to purchase up to an aggregate of 119,050 shares of the Company’s Common Stock. As of March 31, 2007, 47,292 options had been granted and remain outstanding. During the three months ended March 31, 2007, 353 options were exercised and $519 in proceeds were received from this plan.
 
On April 24, 2002, the Board of Directors approved for adoption, effective October 12, 2002, the 2002 Stock Option Plan (“Plan”). The Plan authorizes the grant of options to purchase up to an aggregate of 142,860 shares of the Company’s Common Stock. As of March 31, 2007, 120,454 options had been granted and remain outstanding.

A summary of the Company’s stock option activity and related information for the three months ended March 31, 2007 follows:


   
March 31,
2007
 
Weighted Avg. Exercise Price
 
Outstanding and exercisable, beginning of period
   
337,945
 
$
3.42
 
Granted
   
0
       
Exercised
   
21,783
   
2.85
 
Cancelled
   
396
   
6.30
 
Outstanding and exercisable at the end of period
   
315,766
 
$
3.47
 

The aggregate intrinsic value of options and warrants were $1,360,849 and $735,000, respectively, as of March 31, 2007 for all options and warrants in the money, outstanding and exercisable.
 
10

 
Options outstanding as of March 31, 2007:

   
Outstanding
 
Exercisable
 
Exercise Price
 
Remaining Life (Years)
 
September 1997
   
25,002
   
25,002
 
$
6.30
   
0.6
 
September 1998
   
62,302
   
62,302
 
$
6.62
   
1.6
 
September 1998
   
11,905
   
11,905
 
$
2.10
   
1.6
 
March 2000
   
36,906
   
36,906
 
$
1.89
   
3.0
 
December 2001
   
31,792
   
31,792
 
$
1.47
   
4.9
 
April 2002
   
11,905
   
11,905
 
$
2.10
   
5.1
 
December 2002
   
55,954
   
55,954
 
$
2.36
   
0.7
 
December 2003
   
5,000
   
5,000
 
$
2.26
   
7.0
 
December 2005
   
75,000
   
75,000
 
$
2.88
   
8.9
 
     
315,766
   
315,766
 
$
3.47
   
3.7
 
 
Note 5 - Inventories, net

   
March 31, 2007
 
December 31, 2006
 
               
Raw materials
 
$
1,574,000
 
$
1,449,000
 
Work in process
   
732,000
   
945,000
 
Finished goods
   
6,220,000
   
5,855,000
 
Allowance, excess quantities
   
(293,000
)
 
(275,000
)
               
Inventories, net
 
$
8,233,000
 
$
7,974,000
 
 
Note 6 - Geographic Segment Data

The Company has determined that it operates primarily in one business segment which designs, manufactures and distributes film products for use in packaging and novelty balloon products. The Company operates in foreign and domestic regions. Information about the Company's operations by geographic areas is as follows:
 
   
Net Sales
 
Total Assets at
 
 
 
For the Three Months Ended
March 31,
 
March 31,
 
December 31,
 
 
 
2007
 
2006
 
2007
 
2006
 
                   
United States
 
$
6,344,000
 
$
6,522,000
 
$
25,302,000
 
$
25,256,000
 
Mexico
   
1,596,000
   
1,443,000
   
5,113,000
   
5,050,000
 
United Kingdom
   
870,000
   
813,000
   
2,957,000
   
2,627,000
 
Eliminations
   
(531,000
)
 
(622,000
)
 
(6,693,000
)
 
(6,288,000
)
                           
   
$
8,279,000
 
$
8,156,000
 
$
26,679,000
 
$
26,645,000
 
 
11


 
Note 7 - Cash and Cash Equivalents Concentration

As of March 31, 2007, the Company had cash and cash equivalents deposits at one financial institution that exceeded FDIC limits by $273,000.

Note 8 - Concentration of Credit Risk

Concentration of credit risk with respect to trade accounts receivable is generally limited due to the number of entities comprising the Company's customer base. The Company performs ongoing credit evaluations and provides an allowance for potential credit losses against the portion of accounts receivable which is estimated to be uncollectible. Such losses have historically been within management's expectations. During the three months ended March 31, 2007, there were two customers whose purchases represented more than 10% of the Company’s sales. The sales to each of these customers for the three months ended March 31, 2007 were, $1,625,000 or 19.6% and $1,347,000 or 16.3% of consolidated net sales respectively. Sales to these customers in the same period of 2006 were $1,430,000 or 17.5% and $1,456,000 or 17.8% of consolidated net sales, respectively. For the quarter ended March 31, 2007, the total amount owed by these customers was $1,344,000 or 22.4%, and $1,144,000, or 19.1%, respectively of the consolidated accounts receivables. The amounts owed at March 31, 2006 were $1,156,000, or 20.8%, and $1,250,000, or 22.5% of the consolidated accounts receivable, respectively.

Note 9 - Related Party Transactions 

Stephen M. Merrick, Executive Vice President, Secretary and a Director of the Company, is of counsel to the law firm of Vanasco Genelly and Miller PC which provides legal services to the Company. Legal fees incurred by the Company with this firm for the first quarter of 2007 and 2006, respectively, were $39,000 and $29,000. Also, the Company paid Mr. Merrick $21,000 for services in the first quarter of 2007 and $21,000 in the first quarter of 2006.
 
12

 
John Schwan is a principal of Shamrock Packaging and affiliated companies. The Company made purchases of approximately $105,000 during the three months ended March 31, 2007 and $66,000 during the three months ended March 31, 2006.

John Schwan was an officer of and affiliate of Rapak L.L.C. Rapak purchased $1,625,000 during the three months ended March 31, 2007 and $1,430,000 during the three months ended March 31, 2006. Mr. Schwan ended his relationship with Rapak in the first quarter of 2006. Also, the Company paid Mr. Schwan $16,000 for services in the first quarter of 2007 and $15,000 in the first quarter of 2006.
 
On February 1, 2006, Mr. Schwan and Mr. Merrick advanced $500,000 each to the Company in exchange for (a) five year promissory notes bearing interest at 2% over the prime rate determined quarterly and (b) five year warrants to purchase an aggregate of 303,030 shares of common stock of the Company at the price of $3.30 per share. The fair value of each warrant was estimated as of the date of the grant using the Black-Scholes pricing model.

Interest payments have been made to John H. Schwan and Stephen M. Merrick for loans made to the Company. These interest payments for the three months ended March 31, 2007 totaled $49,000 and $25,000, respectively. In 2006, for the three months ended March 31, 2006, the amounts were $40,000 and $16,000, respectively.
 
Note 10 - New Accounting Pronouncements

In June 2006, the FASB issued FASB Interpretation No. 48, Accounting for Uncertainty in Income Taxes-an interpretation FASB No. 109 (“FIN 48”), which prescribes accounting for and disclosure of uncertainty in tax positions. This interpretation defines the criteria that must be met for the benefits of a tax position to be recognized in the financial statements and the measurement of tax benefits recognized. The provisions of FIN 48 are effective as of the beginning of the Company’s 2007 fiscal year, with the cumulative effect of the change in accounting principle recorded as an adjustment to opening retained earnings. The Company determined that there was no material impact of adopting FIN 48 on the Company’s consolidated financial statements.

Fair Value Positions

In September 2006, the FASB issued SFAS No. 157, “Fair Value Measurements” which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. This statement clarifies how to measure fair value as permitted under other accounting pronouncements but does not require any new fair value measurements. The Company will be required to adopt SFAS No. 157 as of January 1, 2008. The Company is currently evaluating the impact of SFAS No. 157 and has not yet determined the impact on its financial statements.

In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities--including an amendment of FASB Statement No. 115 (“SFAS 159”). SFAS 159 permits companies to choose to measure many financial instruments and certain other items at fair value that are not currently required to be measured at fair value. The objective of SFAS 159 is to provide opportunities to mitigate volatility in reported earnings caused by measuring related assets and liabilities differently without having to apply hedge accounting provisions. SFAS 159 also establishes presentation and disclosure requirements designed to facilitate comparisons between companies that choose different measurement attributes for similar types of assets and liabilities. SFAS 159 will be effective in the first quarter of fiscal 2009. The Company is evaluating the impact that this statement will have on its consolidated financial statements. The adoption of SFAS 159 is not expected to have a material impact on the Company’s financial position, results of operations or cash flows.
 
13

 
Note 11 - Standby Equity Distribution Agreement (SEDA)
 
In July 2006, we entered into a Standby Equity Distribution Agreement (SEDA) with Cornell Capital Partners, LP (“Cornell Capital”) pursuant to which we may, at our discretion, periodically sell to Cornell Capital shares of common stock at a price equal to the volume weighted average price of our common stock on the NASDAQ Capital Market for the five days immediately following the date we notify Cornell Capital of our request. On December 28, 2006, we filed a Registration Statement with the SEC for the registration of 403,500 shares to be sold to Cornell Capital and Newbridge Securities (our placement agent). On January 28, 2007, the registration statement was declared effective. As of March 31, 2007, in connection with the SEDA, we have received $216,500 in net proceeds and recorded a stock subscription receivable for $94,500 from Cornell Capital. Cornell Capital has purchased from us an aggregate of 57,331 shares of our common stock.

Note 12 - Subsequent Events

The Company has issued an additional 59,292 shares to Cornell Capital between March 31, 2007 and April 27, 2007 with net proceeds of $260,000, and a stock subscription receivable of $71,000 as part of the SEDA.
 
On April 27, 2007, the Board of Directors approved a 2007 Stock Incentive Plan (the “Plan”) and authorized the Plan to be submitted to the shareholders of the Company for approval. The Plan authorizes the issuance of awards for up to 150,000 shares our Common Stock in the form of incentive stock options, non-statutory stock options, restricted stock awards and unrestricted stock awards. To date, no awards have been made under the Plan and no awards will be made unless and until the Plan is approved by the shareholders.
 
In December, 2006 the Board approved the retirement of all treasury shares to be effected in 2007.
 
14

 
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations

Overview. We produce film products for novelty, packaging and container applications. These products include metalized balloons, latex balloons and related latex toy products, films for packaging applications, and flexible containers for packaging and storage applications. We produce all of our film products for packaging and container applications at our plant in Barrington, Illinois. We produce all of our latex balloons and latex products at our facility in Guadalajara, Mexico. Substantially all of our film products for packaging applications and flexible containers for packaging and storage are sold to customers in the United States. We market and sell our novelty items - principally metalized balloons and latex balloons - in the United States, Mexico, the United Kingdom and a number of additional countries.
 
15


Results of Operations

Net Sales. For the three months ended March 31, 2007, net sales were $8,279,000 compared to net sales of $8,156,000 for the same period of 2006, an increase of 1.5%. For the quarters ended March 31, 2007 and 2006, net sales by product category were as follows: 
 
   
 Three Months Ended
 
   
March 31, 2007
 
March 31, 2006
 
   
$
 
% of
 
$
 
% of
 
Product Category
 
(000) Omitted
 
Net Sales
 
(000) Omitted
 
Net Sales
 
                   
Metalized Balloons
   
3,999
   
48
%
 
3,674
   
45
%
                           
Films
   
1,826
   
22
%
 
1,783
   
22
%
                           
Pouches
   
665
   
8
%
 
983
   
12
%
                           
Latex Balloons
   
1,516
   
19
%
 
1,519
   
19
%
                           
Helium/Other
   
273
   
3
%
 
197
   
2
%
 
The increase in metalized balloon sales for three months ended March 31, 2007, compared to the same period of 2006 is attributable to the addition of two new customers in 2007. Sales to these customers totaled $390,000.

The decline in pouch sales is attributable principally to the reduction in sales to one customer by approximately $199,000. We anticipate continued sales of pouches to this customer under our supply agreement with this customer.

Sales to a limited number of customers continue to represent a large percentage of our net sales. The table below illustrates the impact on sales of our top two and ten customers for the three months ended March 31, 2007 and 2006.
 
16

 
   
Three Months Ended
 
           
   
% of Net Sales
 
   
March 31, 2007
 
March 31,2006
 
           
Top 2 customers
   
35.9
%
 
35.3
%
               
Top 10 Customers
   
64.1
%
 
58.4
%
 
During the three months ended March 31, 2007, there were two customers whose purchases represented more than 10% of the Company’s sales. The sales to each of these customers for the three months ended March 31, 2007 were $1,625,000 or 19.6% and $1,347,000 or 16.3% of net sales respectively. Sales to these customers in the same period of 2006 were $1,430,000 or 17.5% and $1,456,000 or 17.8%, of net sales, respectively. For the quarter ended March 31, 2007, the total amount due from these customers to the Company was $1,344,000 and $1,144,000 respectively. The balances owed at March 31, 2006 were $1,156,000 and $1,250,000 respectively.

Cost of Sales. Cost of sales in the first quarter of 2007 were $6,376,000 or 77% compared to cost of sales of $6,203,000 or 76% in the first quarter of 2006. In addition to the slightly higher rate of sales in the first quarter of 2007, the Company incurred production overhead expenses in that quarter related to the improvements to the facility in Barrington, Illinois and preparation for the production of a new line of pouch products.
 
General and Administrative. For the three months ended March 31, 2007, general and administrative expenses were $1,212,000 or 14.6% of net sales, compared to $1,017,000 or 12.5% of net sales for the same period in 2006. The increase included additions in administrative staff and compensation rates and increases in legal fees.

Selling. For the three months ended March 31, 2007, selling expenses were $206,000 or 2.5% of net sales for the quarter, compared to $177,000 or 2.2% of net sales for the same three months of 2006. The increase in selling expense is attributable to increased royalties and commissions paid on sales to new customers.

Advertising and Marketing. For the three months ended March 31, 2007, advertising and marketing expenses were $291,000 or 3.5% of net sales for the period, compared to $218,000 or 2.7% of net sales for the same period of 2006. The change in advertising and marketing was principally due to an increase in the amortization of artwork and printing plate costs that were expensed in the period as compared to the prior period.

Other Income (Expense). During the three months ended March 31, 2007, the Company incurred net interest expense of $335,000, compared to net interest expense during the same period of 2006 of $331,000.
 
17


During the three months ended March 31, 2007, the Company had other income of $52,000 compared to other income of $48,000 during the first quarter of 2006. Both amounts consisted of foreign currency transaction gains.

Income Taxes. For the three months ended March 31, 2007, the income tax benefit of $36,000 related to the loss recorded in the U.S. This was offset by a provision for income taxes in the United Kingdom for CTI Balloons, Ltd, the Company’s subsidiary in the United Kingdom and in Mexico for Flexo Universal, S.A. de C.V., the Company’s subsidiary in Mexico. For the same period of 2006, the Company recorded an income tax expense of $38,000.

Net (Loss) Income. For the three months ended March 31, 2007, the Company had net loss of $52,000 or $0.02 per share (basic and diluted), compared to net income for the same period of 2006 of $220,000 or $0.11 per share basic and $0.10 diluted. For the three months ended March 31, 2007, the Company had net income from operations (before interest, taxes and non-operating items) of $194,000, compared to net income from operations of $541,000 during the same period of 2006. The difference in net income between the first quarter of 2007 and 2006 is attributable principally to increased administrative, selling and marketing costs incurred in the United States operations.

Financial Condition, Liquidity and Capital Resources 

Cash Flow Items.

Operating Activities. During the quarter ended March 31, 2007, net cash provided by operations was $529,000, compared to net cash used in operations during three months ended March 31, 2006 of $945,000.

Significant changes in working capital items during the three months ended March 31, 2007 consisted of (i) a decrease in accounts receivable of $372,000, (ii) an increase in inventory of $290,000, (iii) depreciation and amortization of $359,000, (iv) an increase in trade payable of $133,000 and (v) a decrease in accrued liabilities of $99,000. We do anticipate some increases in depreciation during the balance of 2007 due to additional equipment purchases relating to product line extension and building improvements.

Investing Activity. During the three months ended March 31, 2007, cash used in investing activity was $327,000, compared to $61,000 in same period of 2006. We do anticipate incurring additional capital expenditures during the balance of 2007 for improvements and for the acquisition of production equipment.

Financing Activities. For the three months ended March 31, 2007, cash used in financing activities was $122,000 compared to cash provided by financing activities for the same period of 2006 in the amount of $1,379,000. In the first quarter of 2007 financing activities included the receipt of $105,000 from the sale of common stock and payment of long term debt obligations of $268,000.

Liquidity and Capital Resources. At March 31, 2007, the Company had a cash balance of $466,000. At March 31, 2007, the Company had a working capital balance of $1,823,000 compared to a working capital balance of $1,848,000 at December 31, 2006.
 
18


The Company's current cash management strategy includes utilizing the Company's revolving line of credit for liquidity. Under our line of credit with Charter One Bank, we are entitled to borrow an amount equal to 85% of eligible receivables and 60% of eligible inventory, up to a maximum of $7,000,000. Foreign receivables and inventory held by our foreign subsidiaries are not eligible. In addition, in order to be permitted to make advances under the line of credit, we are required to meet various financial covenants. As of March 31, 2007, we had complied with all applicable financial covenants in the loan agreement. Based on our results to date for the year and our projected results of operations for the balance of this year, we believe we will be in compliance with all applicable financial covenants of the loan agreement for the balance of 2007. Further, we believe that with our present cash and working capital and the amounts available to us under our line of credit and through sales of common stock, we will have sufficient funds to enable us to meet our obligations through the next twelve months.

The loan agreement provides for interest at varying rates in excess of the Bank’s prime rate, depending on the level of senior debt to EBITDA over time. As of March 31, 2007, the applicable premium being applied was 0.25%

Also, under the loan agreement, we were required to purchase a swap agreement with respect to at least 60% of the mortgage and term loan portions of our loan. On April 5, 2006, we entered into a swap arrangement with Charter One Bank with respect to 60% of the principal amounts of the mortgage loan and the term loan, which had the effect of fixing the interest rate for such portions of the loans at 8.49% for the balance of the loan terms. These swap arrangements are subject to some market variation due to market interest rate variability. Management believes that these variations will not materially affect the results of the Company. As of March 31, 2007, the net effect of these market adjustments were $61,000, which has been recorded in the Company’s consolidated financial statements. The net effect for the three months ending March 31, 2007 was additional interest expense of $6,000.

On June 6, 2006, we entered into a Standby Equity Distribution Agreement with Cornell Capital pursuant to which we may, at our discretion, periodically sell to Cornell Capital shares of common stock for a total purchase price of up to $5 million. For each share of common stock purchased under the Standby Equity Distribution Agreement, Cornell Capital will pay one hundred percent (100%) of the lowest volume weighted average price (as quoted by Bloomberg, LP) of our common stock on the NASDAQ Capital Market or other principal market on which our common stock is traded for the five (5) days immediately following the notice date. The number of shares purchased by Cornell Capital for each advance is determined by dividing the amount of each advance by the purchase price for the shares of common stock. Furthermore, Cornell Capital will receive five percent (5%) of each advance in cash under the Standby Equity Distribution Agreement as an underwriting discount. Cornell’s obligation to purchase shares of our common stock under the Agreement is subject to certain conditions, including: (i) we have obtained an effective registration statement for the shares of common stock sold to Cornell under the Agreement and (ii) the amount of each advance requested by us under the Agreement shall not be more than $100,000.
 
We are permitted to make draws on the Standby Equity Distribution Agreement only so long as Cornell Capital’s beneficial ownership of our common stock remains lower than 9.9% and a possibility exists that Cornell Capital may own more than 9.9% of CTI’s outstanding common stock at a time when we would otherwise plan to make an advance under the Standby Equity Distribution Agreement. We do not have any agreements with Cornell Capital regarding the distribution of such stock, although Cornell Capital has indicated that it intends promptly to sell any stock received under the Standby Equity Distribution Agreement.
 
19

 
We cannot predict the actual number of shares of common stock that will be issued pursuant to the Standby Equity Distribution Agreement, in part, because the purchase price of the shares will fluctuate based on prevailing market conditions, and we have not determined the total amount of advances we intend to draw. We have registered 400,000 shares of common stock for the sale under the Standby Equity Distribution Agreement. The Company and Cornell have agreed that the Company will not sell to Cornell Capital in excess of 400,000 shares unless and until the Company shall have obtained shareholder approval for such sales.
 
On December 28, 2006, we filed a Registration Statement for the registration of 403,500 shares of our common stock. On January 26, 2007, the Registration Statement was declared effective. Since that time, to May 18, 2007, we have sold an aggregate of 116,603 shares of common stock to Cornell under the SEDA and have received net proceeds from the sale of those shares in the amount of $642,000. We intend to continue to sell shares to Cornell under the SEDA.

Seasonality

In recent years, sales in the metalized balloon product line have historically been seasonal with approximately 45% occurring in the period from December through March and 21% being generated in the period from July through October. The sale of latex balloons and laminated film products have not historically been seasonal.

Critical Accounting Policies

A summary of our critical accounting policies and estimates is presented on pages 42 and 43 of our 2006 Annual Report on Form 10-K, as filed with the Securities and Exchange Commission.

Item 3. Quantitative and Qualitative Disclosures Regarding Market Risk 

The Company is exposed to various market risks, primarily foreign currency risks and interest rate risks.

The Company’s earnings are affected by changes in interest rates as a result of variable rate indebtedness. If market interest rates for our variable rate indebtedness average 1% more than the interest rate actually paid for the first quarter ended March 31, 2007 and 2006, our interest rate expense would have increased, and income before income taxes would have decreased by $23,474 and $26,547 for these quarters, respectively. These amounts are determined by considering the impact of the hypothetical interest rates on our borrowings. This analysis does not consider the effects of the reduced level of overall economic activity that could exist in such an environment. Further, in the event of a change of such magnitude, management would likely take actions to reduce our exposure to such change. However, due to the uncertainty of the specific actions we would take and their possible effects, the sensitivity analysis assumes no change in our financial structure.
 
20


The Company’s earnings and cash flows are subject to fluctuations due to changes in foreign currency rates, particularly the Mexican peso and the British pound, as the Company produces and sells products in Mexico for sale in the United States and other countries and the Company’s UK subsidiary purchases balloon products from the Company in dollars. Also, the Mexican subsidiary purchases goods from external sources in U.S. dollars and is affected by currency fluctuations in those transactions. Substantially all of the Company’s purchases and sales of goods for its operations in the United States are done in U.S. dollars. However, the Company’s level of sales in other countries may be affected by currency fluctuations. As a result, exchange rate fluctuations may have an effect on sales and gross margins. Accounting practices require that the Company’s results from operations be converted to U.S. dollars for reporting purposes. Consequently, the reported earnings of the Company in future periods may be affected by fluctuations in currency exchange rates, generally increasing with a weaker U.S. dollar and decreasing with a strengthening U.S. dollar. To date, we have not entered into any transactions to hedge against currency fluctuation results.
 
We have performed a sensitivity analysis as of March 31, 2007 that measures the change in the results of our foreign operations arising from a hypothetical 10% adverse movement in the exchange rate of all of the currencies the Company presently has operations in. Using the results of operations for the first quarter of 2007 and 2006 for the Company’s foreign operations as a basis for comparison, an adverse movement of 10% would create a potential reduction in the Company’s net income, or increase its net loss before taxes, in the amount of $45,221 and $44,860 for each of those quarters, respectively.

The Company is also exposed to market risk in changes in commodity prices in some of the raw materials it purchases for its manufacturing needs. However, this presents a risk that would not have a material effect on the Company’s results of operations or financial condition.

Item 4. Controls and Procedures 

(a) Evaluation of disclosure controls and procedures: Our principal executive officer and principal financial officer have reviewed and evaluated the effectiveness of the Company’s disclosure controls and procedures as of March 31, 2007. Based on such review and evaluation, our chief executive officer and chief financial officer have concluded that, as of such date, our disclosure controls and procedures were adequate and effective to ensure that the information required to be disclosed by the Company in the reports it files or submits under the Securities Exchange Act of 1934, as amended (a) is recorded, processed, summarized and reported within the time period specified in the SEC’s rules and forms and (b) is accumulated and communicated to the Company’s management, including the officers, as appropriate to allow timely decisions regarding required disclosure.
 
(b) Changes in internal controls: There were no significant changes in our internal controls or in other factors that could significantly affect the Company’s disclosure controls and procedures subsequent to the date of their evaluation, nor were there any significant deficiencies or material weaknesses in the Company’s internal controls. As a result, no corrective actions were required or undertaken.
 
21

 
Part II. OTHER INFORMATION

Item 1. Legal Proceedings

On December 20, 2006, Pliant Corporation filed an action against the Company in the Circuit Court of Cook County, Illinois. In the action, Pliant claims that there is due from the Company to Pliant the sum of $245,000 for goods sold and delivered by Pliant to the Company as well as interest on such amount. On February 21, 2007, the Company filed and answer to the complaint and counterclaim denying liability and asserting certain claims against Pliant for damages for the sale by Pliant to the Company of defective products. Management intends to defend the claims of Pliant in this action and to pursue its counterclaims and believes that the Company has established adequate reserves regarding the claim.

In addition, the Company is party to certain lawsuits or claims arising in the normal course of business. The ultimate outcome of these matters is unknown, but in the opinion of management, we do not believe any of these proceedings or claims will have, individually or in the aggregate, a material adverse effect upon our financial condition or future results of operation.

Item 1A. Risk Factors

There have been no material changes from the risk factors as disclosed in the Company’s Form 10-K in response to Item 1A to Part I of Form 10-K.
 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

On January 6, 2007, the Company reserved 17,000 shares of common stock to Capstone Advisory Group in consideration of management consulting services to be performed over a period of 18 months. The shares will be issued on a restricted basis for investment only and the sale will not be registered in reliance upon an exemption from registration for non-public offerings.
 
Item 3. Defaults Upon Senior Securities

Not applicable.

Item 4. Submission of Matters to a Vote of Security Holders

Not applicable.
 
Item 5.  Other Information

The Certifications of the Chief Executive Officer and the Chief Financial Officer of Registrant Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 are attached as Exhibits to this Report on Form 10-Q.
 
22


Item 6. Exhibits

The following are being filed as exhibits to this report: *
 
Exhibit No.
 
Description
     
3.1
 
Third Restated Certificate of Incorporation of CTI Industries Corporation (incorporated by reference to Exhibit A contained in Registrant’s Schedule 14A Definitive Proxy Statement for solicitation of written consent of shareholders, as filed with Commission on October 25, 1999)
     
3.2
 
By-laws of CTI Industries Corporation (incorporated by reference to Exhibits, contained in Registrant’s Form SB-2 Registration Statement (File No. 333-31969) effective November 5, 1997)
     
31.1
 
Sarbanes-Oxley Act Section 302 Certifications for Howard W. Schwan
     
31.2
 
Sarbanes-Oxley Act Section 302 Certification for Stephen M. Merrick
     
32.1
 
Sarbanes-Oxley Act Section 906 Certification for Stephen M. Merrick, Chief Financial Officer
     
32.2
 
Sarbanes-Oxley Act Section 906 Certification for Howard W. Schwan, Chief Executive Officer
 
* Also incorporated by reference the Exhibits filed as part of the SB-2 Registration Statement of the Registrant, effective November 5, 1997, and subsequent periodic filings.
 
23

 
SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
     
Dated: May 21, 2007    
CTI INDUSTRIES CORPORATION
 
 
 
 
 
 
  By:   /s/ Howard W. Schwan
 
Howard W. Schwan, President
     
     
By:   /s/ Stephen M. Merrick
 
Stephen M. Merrick
Executive Vice President and
Chief Financial Officer 
 
24